Skip to main content

FDA recall, , Moderate risk

Medartis APTUS TriLock Screws

APTUS TriLock Screws may be mixed up between specified lots of 2.5mm and 2.8mm outer diameter screws.

What happened

Medartis AG, based in Basel Town, Switzerland, voluntarily recalled certain APTUS TriLock Screws because of a mix up between specified lots of 2.5mm and 2.8mm outer diameter screws. The recall involves the Aptus 2.8 TriLock Screw 16mm, model/catalog number A-5850.16/1, with a quantity of 126 units. The APTUS fixation systems are used for fractures, osteotomies and arthrodesis of the hand, forearm, shoulder and foot.

The company began the recall on January 9, 2026, and customers were notified by letter. The recall was added to the FDA's Enforcement Report and classified on March 10, 2026, and included in the FDA's weekly enforcement report on March 18, 2026. Distribution was worldwide, including US nationwide distribution in Indiana and Pennsylvania, and the countries of Austria, Belgium, Switzerland, Czech Republic, Germany, Spain, Finland, France, Israel, Italy, Japan, and Poland.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

2 products

Match the lot code and model/catalog number listed under your product.

  1. APTUS 2.5 TriLock Screw 16mm, HD7, 1/Pkg

    Model/Catalog number
    • A-5750.16/1
    Lot code
    • 2.5
    • 16mm
    • HD7
    • 25472432
  2. APTUS 2.8 TriLock Screw 16mm, HD7, 1/Pkg

    Model/Catalog number
    • A-5850.16/1
    Lot code
    • 2.8
    • 16mm
    • HD7
    • 25467933

Recall details

Company began the recall
Sold in

Worldwide - US Nationwide distribution in the states of Indiana and Pennsylvania and the countries of Austria, Belgium, Switzerland, Czech Republic, Germany, Spain, Finland, France, Israel, Italy, Japan, and Poland.

Company
Medartis AGBasel Town, Switzerland
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98353
Recall numbers
Z-1549-2026 to Z-1550-2026
Recall type
Voluntary: Firm initiated
How the company first told customers
Letter

All recalls from Medartis AG

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)